Zoetis | ZTS - Sales Revenues


Zoetis reported $2.5B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
AbbVie USD 16.99B 1.99B Jun/2026
Align Technology USD 1.06B 20M Jun/2026
Bayer EUR 10.87B 2.54B Jun/2026
Bristol-Myers Squibb USD 12.97B 1.48B Jun/2026
Charles River Laboratories USD 1000M 4.2M Jun/2026
Coherus Biosciences USD 12.75M 1.18M Dec/2025
Dentsply International USD 898M 18M Jun/2026
Eli Lilly USD 22.97B 3.17B Jun/2026
Henry Schein USD 3.46B 90M Jun/2026
Idexx Laboratories USD 1.22B 80M Jun/2026
Illumina USD 1.16B 70M Jun/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
J&J USD 25.4B 89M Sep/2026
Laboratory Of America USD 3.73B 190M Jun/2026
Merck USD 16.6B 310M Jun/2026
Neogen USD 222.8M 2.5M Jun/2026
Pacira USD 192.4M 15.4M Jun/2026
Perrigo USD 1.02B 51M Jun/2026
Pfizer USD 15.03B 530M Jun/2026
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Quest Diagnostics USD 3.1B 57M Sep/2026
Sanofi EUR 11.95B 710M Jun/2026
Sanofi EUR 12.14B 65M Mar/2026
Zoetis USD 2.5B 200M Jun/2026